What does Lotus Pharmaceuticals, Inc. do?

Lotus Pharmaceuticals, Inc. (LTUS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is LTUS's market cap?

Lotus Pharmaceuticals, Inc. (LTUS) has a market capitalization of approximately $82,311, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does LTUS pay a dividend?

No — Lotus Pharmaceuticals, Inc. (LTUS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Lotus Pharmaceuticals, Inc. (LTUS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

LTUS

Lotus Pharmaceuticals, Inc.

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00−13.04%

Market cap$82.31K·Market closed·Aug 27 8:00 PM UTC

Price Chart

$0.00−$0.00 (−13.04%)today

−87.50%CAGR −34.06%

Select date range

FromTo

Aug 9, 2005Aug 29, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

LTUS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 12

Last Report DateNov 10

Reported vs Estimate$0.05

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$30.15K

Net Margin—

Operating Cash Flow−$16.40K

Capital Expenditures$0.00

Free Cash Flow−$16.40K

Return on Equity—

Return on Invested Capital0.0%

Net Debt$123.01K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for LTUS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how LTUS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LTUS and 80,000+ other tickers.

About Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.

CEO: Zhong Yi Liu
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: OTC
Employees: 233
Website: lotuspharmaceuticalsusa.com

Peers

Peers Tab

CDSG

China Dongsheng International, Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About LTUS

What does Lotus Pharmaceuticals, Inc. do?: Lotus Pharmaceuticals, Inc. (LTUS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is LTUS's market cap?: Lotus Pharmaceuticals, Inc. (LTUS) has a market capitalization of approximately $82,311, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does LTUS pay a dividend?: No — Lotus Pharmaceuticals, Inc. (LTUS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is LTUS profitable?: Lotus Pharmaceuticals, Inc. (LTUS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.